Index

Methodology

The Index is designed to be a reviewed professional reference, not a directory scraped from marketing pages.

Inclusion criteria

A product, company, or tool area is eligible when it has a neurosurgical use case and at least one verifiable public signal: a regulatory record, a peer-reviewed publication, a clinical trial entry, a documented hospital deployment, or a company source that can be independently checked.

Primary sources

Regulatory status should be checked against primary databases whenever possible: FDA 510(k), De Novo, and PMA records; CE and notified-body documentation where available; NMPA registrations; publications; trial registries; and official company documentation.

Clinical notes

Each reviewed row should include a short clinical note about evidence quality, workflow fit, or adoption friction. These notes are editorial judgments, not endorsements and not medical advice.

Review cadence

Every row should carry a last-reviewed date. Rows older than twelve months should be treated as potentially stale until rechecked.